Health groups disappointed over SC's stand on vaccines case

Image
Press Trust of India New Delhi
Last Updated : Feb 20 2018 | 8:55 PM IST
Health groups today expressed disappointment over the Supreme Court refusing to recall its earlier order in which it had disposed of a plea seeking an enquiry into alleged negligence by the government in running public sector laboratories involved in making vaccines.
The groups are now considering filing a fresh petition, as the court also said in case there is any deficiency or neglect on the part of the Government... the petitioner shall be free to seek appropriate redress in appropriate proceedings at the appropriate stage.
Dr Mira Shiva of AIDAN, a petitioner in the case, claimed the court relied only on the governments claims regarding revival and modernisation of suspended public sector laboratories and did not take into account the last rejoinder of the petitioners that highlighted the increasing diversion of purchase orders to private sector at ever-increasing prices.
The PIL was filed by former Union health secretary SP Shukla and representatives of the All India Drug Action Network (AIDAN), Low Cost Standard Therapeutics (LOCOST), Medico Friend Circle (MFC), and Society for Scientific Values (SSV).
Shukla, who is the main petitioner, said they have won half the battle with the revival of the suspended PSUs and their modernisation for compliance with good manufacturing practices (GMP), under the pressure of the case.
"But their production is yet to be restored to pre-suspension levels, the responsibility for mala fide suspension was not fixed, and even the recommendations of the Javid Chowdhury Committee have not been fully implemented," he said.
According to S Srinivasan of LOCOST, the government has not been buying vaccines from the public sector even after their revival.
"Government data show that purchase orders to PSUs are declining and those to private companies are growing despite increasing prices. We highlighted all these issues in our last affidavit on 2016 to show that the Government of India is misleading the Supreme Court, but it was not taken into account," Srinivasan said.
"We neither have a rational vaccine policy nor rational use of vaccines. For example, selective immunisation has disappeared from government policy. New vaccines and their combinations of doubtful efficacy and safety are being introduced in the universal immunisation programme.
"By shifting its procurement towards irrational cocktail vaccines made only by the private sector, the government is systematically reducing PSUs into component suppliers to the private sector," Dr Shiva alleged.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Feb 20 2018 | 8:55 PM IST

Next Story